The Kidney Disease: Improving Global Outcomes (KDIGO) group has released its 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney ...

This episode, titled Rethinking KDIGO Guidance and Payer Models in the Era of Targeted IgA Nephropathy Therapies, features expert nephrologists discussing the following critical questions: What ...

SAN DIEGO & ST. GALLEN, Switzerland, September 26, 2025--(BUSINESS WIRE)--CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice ...

Monitoring calcium, phosphorus, PTH and alkaline phosphatase regularly and basing therapeutic decisions on trends rather than single laboratory values is the best approach to managing mineral and bone ...

Please provide your email address to receive an email when new articles are posted on . The inclusion of kidney health measures, as recommended by Kidney Disease: Improving Global Outcomes, led to ...

The newly lowered Kidney Disease: Improving Global Outcomes (KDIGO) blood pressure (BP) target systolic BP (SBP) of <120 mm Hg is associated with improved outcomes compared with the 2012 KDIGO BP ...

Please provide your email address to receive an email when new articles are posted on . Kidney Disease: Improving Global Outcomes is prioritizing its evidence-based guidelines, expanding the guideline ...

BP Meds May Not Eliminate CVD Risk The new KDIGO guideline recommendation to target a systolic blood pressure of less than 120 mm Hg in many patients with nondialysis CKD is lower than the target ...

The new KDIGO anaemia guidelines represent a bold, sensible, and patient-centred approach to anaemia management in patients with chronic kidney disease. Recommendations regarding haemoglobin targets, ...

Medscape Nephrology is pleased to present the Kidney Disease: Improving Global Outcomes (KDIGO) Guideline for Hepatitis C in Chronic Kidney Disease (CKD), which were presented on April 4 at the ...